News - Pricing

Filter

Current filters:

Pricing

Popular Filters

610 to 634 of 675 results

BASF hikes prices for pharmaceutical excipients and active ingredients

30-08-2011

Effective September 1, 2011, Germany-based BASF (BAS: XE), the world’s largest chemical company,…

BASFGenericsPharmaceuticalPricing

Diabetes treatments now 8.4% of UK annual NHS drugs bill, says report

24-08-2011

Diabetes prescriptions now account for 8.4 per of the entire National Health Service net bill for primary…

DiabetesEuropeHealthcareMarkets & MarketingPharmaceuticalPricing

AstraZeneca breast cancer drug Faslodex not good use of NHS resources, says NICE draft guidance

24-08-2011

An independent committee of experts that develops guidance on behalf of the UK drugs watchdog the National…

AstraZenecaEuropeFaslodexOncologyPharmaceuticalPricingRegulation

Australian Senate report slams Cabinet PBS deferrals

17-08-2011

A Committee report tabled in the Australian Parliament yesterday strongly criticising the government’s…

Asia-PacificPharmaceuticalPoliticsPricingRegulation

Drug shortages in USA leading to price gouging, possible safety issues

17-08-2011

As health care providers in the USA deal with record rates of drug shortages, some “gray market"…

GenericsHealthcareMarkets & MarketingNorth AmericaPharmaceuticalPricing

South Korea to cut pharma prices by average 17% to save $1.94 billion

15-08-2011

In a move that is likely to curb current growth prospects for the pharmaceutical industry in South Korea,…

Asia-PacificGenericsPharmaceuticalPricing

UK’s NICE calls for more data on Roche’s RoActemra for sJIA

11-08-2011

In a draft guidance published yesterday, UK drugs watchdog the National Institute for Health and Clinical…

Anti-Arthritics/RheumaticsEuropePharmaceuticalPricingRegulationRoActemraRoche

US Medicare prescription drug premiums will not increase, says HHS

08-08-2011

In the USA, Medicare average prescription drug premiums will not increase in 2012. The announcement from…

FinancialHealthcareNorth AmericaPharmaceuticalPricing

China implements further drug prices cuts, reducing 82 medicines by 14%

08-08-2011

China will lower the retail price ceiling of 82 pharmaceutical products drugs by an average 14% in a…

Asia-PacificPharmaceuticalPricing

UK’s NICE turns down Novartis MS drug Gilenya in draft guidance

07-08-2011

In provisional draft guidance published last Friday, UK drugs watchdog the National Institute for Health…

EuropeGilenyaNeurologicalNovartisPharmaceuticalPricingRegulation

Novartis appeals UK NICE negative decision on Lucentis in DME

03-08-2011

The UK subsidiary of Swiss drug major Novartis (NOVN: VX) has lodged an appeal against the decision last…

EuropeLucentisNovartisOphthalmicsPharmaceuticalPricingRegulation

UK’s NICE backs use of TMC’s Angiox for STEMI patients undergoing primary PCI

27-07-2011

Following a previous positive draft guidance, the UK drugs watch dog the National Institute for Health…

AngioxCardio-vascularEuropePharmaceuticalPricingRegulationThe Medicines Company

Australian PBS deferrals risk creating two-tier health system, drugmakers argue

25-07-2011

Federal Cabinet’s decision to defer the listing of new medicines on the Pharmaceutical Benefits…

Asia-PacificGenericsHealthcarePharmaceuticalPoliticsPricing

Prescription drugs equally affordable in Canada and USA

21-07-2011

Government intervention in Canada’s prescription drug market through regulation, price controls,…

HealthcareNorth AmericaPharmaceuticalPricing

Australian Cabinet’s PBS deferrals mean patients miss out

21-07-2011

Australia’s federal Cabinet’s decision to defer the listing of new medicines on the Pharmaceutical…

Asia-PacificPharmaceuticalPricingRegulation

Negative draft guidance from UK’s NICE for Eisai’s Halaven

20-07-2011

In yet another negative opinion for breast cancer use on the UK’s National Health Service, UK drugs…

EisaiEuropeHalavenOncologyPharmaceuticalPricingRegulation

MSF slams drugmakers for shutting down HIV drug discount programs in mid-income countries

19-07-2011

Several pharmaceutical companies have abandoned HIV drug discount programs in middle-income countries,…

Anti-viralsGlobalPharmaceuticalPricing

UK MoH reports on value-based medicines pricing consulation

18-07-2011

The UK Department of Health has reported on its consultation on value-based pricing for medicines, in…

EuropePharmaceuticalPoliticsPricing

610 to 634 of 675 results

Back to top